Free Trial
OTCMKTS:GNWSF

StageZero Life Sciences (GNWSF) Stock Price, News & Analysis

StageZero Life Sciences logo
$0.03 0.00 (0.00%)
As of 06/20/2025

About StageZero Life Sciences Stock (OTCMKTS:GNWSF)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.00
$0.03
52-Week Range
$0.00
$1.27
Volume
N/A
Average Volume
26,719 shs
Market Capitalization
$1.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

StageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. It also offers Aristotle, a multi-cancer panel test for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer; and COVID PCR testing and blood test analysis. StageZero Life Sciences Ltd. is headquartered in Richmond Hill, Canada.

Receive GNWSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

GNWSF Stock News Headlines

New Rule Hits in July — The Smart Money Already Moved
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

GNWSF Stock Analysis - Frequently Asked Questions

StageZero Life Sciences' stock was trading at $0.0016 on January 1st, 2025. Since then, GNWSF shares have increased by 1,692.9% and is now trading at $0.0287.
View the best growth stocks for 2025 here
.

Shares of GNWSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
OTCMKTS:GNWSF
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.86 million
Net Margins
-200.26%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.15 million
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
-1.43

Miscellaneous

Free Float
N/A
Market Cap
$1.81 million
Optionable
Not Optionable
Beta
0.28

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (OTCMKTS:GNWSF) was last updated on 6/22/2025 by MarketBeat.com Staff
From Our Partners